English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Methods Retrospective longitudinal assessment of all HIV+ patients who received RAL at our institution until June 2008. Overall, the drug was prescribed as part of a salvage regimen or in patients with undetectable plasma HIV-RNA under another regimen as part of a switch strategy due to intolerance or toxicity to the previous combination. Data were recorded at baseline and during 48 weeks of follow-up.

Raltegravir: a potent and safe integrase inhibitor with a favourable impact on cardiovascular and liver profile